drugset / Trial / NCT00069862
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
Non-randomizedCrossoverOpen-labelTreatment
Summary
A clinical trial designed to compare the safety and iron excretion properties of desferoxamine (DFO) and deferitrin (GT56-252), an experimental oral iron chelator.
Timeline
- Start
- 2003-09
- Primary completion
- —
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferitrin | Small molecule | — | Oral |
| Subject | desferoxamine | Unknown | — | — |